Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fragile X syndrome

L Chakrabarti1, K E Davies

  • 1Biochemistry Department, Oxford University, Oxford, UK.

Current Opinion in Neurology
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Fragile X syndrome, a genetic disorder, is caused by an expanded CGG repeat in the FMR1 gene. This expansion leads to the absence of the fragile X mental retardation protein, impacting brain development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Universal DNA methylation age across mammalian tissues.

Nature aging·2023
Same author

Universal DNA methylation age across mammalian tissues.

Nature aging·2023
Same author

Syncoilin is an intermediate filament protein in activated hepatic stellate cells.

Histochemistry and cell biology·2013
Same author

UTRN on chromosome 6q24 is mutated in multiple tumors.

Oncogene·2007
Same author

Utrophin upregulation in Duchenne muscular dystrophy.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2006
Same author

A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours.

Neuromuscular disorders : NMD·2005
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Genetics
  • Neuroscience
  • Developmental Biology

Background:

  • Fragile X syndrome is a leading inherited cause of intellectual disability.
  • It is characterized by specific clinical features including cognitive impairment and distinct facial morphology.
  • A fragile site on the X chromosome (Xq27.3) is a hallmark of the condition.

Purpose of the Study:

  • To elucidate the genetic basis of fragile X syndrome.
  • To understand the molecular mechanism underlying the absence of the fragile X mental retardation protein.
  • To explore the protein's role in neuronal development.

Main Methods:

  • Genetic analysis to identify CGG repeat expansion.
  • Molecular studies to confirm the absence of the FMR1 protein.

Related Experiment Videos

  • Investigating the function of the FMR1 protein in neuronal pathways.

    • Main Results:

    • Confirmed an expansion of a CGG repeat sequence at the 5' end of the FMR1 gene.
    • Demonstrated that this expansion results in the absence of the functional fragile X mental retardation protein.
    • Identified the protein's crucial role in RNA processing and neuronal maturation.

    Conclusions:

    • The CGG repeat expansion in the FMR1 gene is the direct cause of fragile X syndrome.
    • The absence of the fragile X mental retardation protein disrupts normal brain development.
    • Understanding this mechanism provides targets for future therapeutic interventions.